Loading

Please wait...

Vantas

Generic Name: histrelin (implant) (his TREL in)
Brand Names: Supprelin LA, Vantas
Vantas is an implant containing a man-made form of a hormone and is used to treat symptoms of prostate cancer in men. Learn about side effects, interactions and indications.
  • Prescription Settings
  • X

Prices and coupons of Vantas

Set your location
for drug prices near you

Enter your zip code

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Vantas (histrelin) is a man-made form of a hormone that regulates many processes in the body. Histrelin overstimulates the body's own production of certain hormones, which causes that production to shut down temporarily. The Vantas implant is used to treat symptoms of prostate cancer in men. Vantas treats only the symptoms of prostate cancer but does not treat the cancer itself. Vantas can cause side effects such as crying spells, anger, aggression, and feeling restless or irritable. Call your doctor if you have any new or worsening mental problems. Learn more

Vantas Side Effects

Vantas Side Effects

Note: This document contains side effect information about histrelin. Some of the dosage forms listed on this page may not apply to the brand name Vantas.

For the Consumer

Applies to histrelin: subcutaneous implant

Along with its needed effects, histrelin (the active ingredient contained in Vantas) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking histrelin:

Rare

  • Bloody urine
  • decreased frequency or amount of urine
  • increased thirst
  • loss of appetite
  • lower back or side pain
  • nausea
  • swelling of the face, fingers, or lower legs
  • trouble breathing
  • unusual tiredness or weakness
  • vomiting
  • weight gain

Incidence not known

  • Bloating of the stomach
  • dark urine
  • discouragement
  • feeling sad or empty
  • irritability
  • light-colored stools
  • loss of interest or pleasure
  • seizures
  • stomach pain
  • trouble concentrating
  • trouble sleeping
  • yellow eyes or skin

Some side effects of histrelin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Decrease in testicle size
  • feeling of warmth
  • local infection, irritation, pain, redness, or swelling on the skin where the implant was placed
  • redness of the face, neck, arms, and upper chest
  • sudden sweating

Less common

  • Decreased interest in sexual intercourse
  • difficulty having a bowel movement
  • flushing or redness of the skin
  • headache
  • inability to have or keep an erection
  • loss in sexual ability, desire, drive, or performance
  • swelling of the breast or breast soreness in both females and males
  • unusually warm skin

For Healthcare Professionals

Applies to histrelin: subcutaneous implant, subcutaneous kit

Endocrine

Common (1% to 10%): Elevated blood glucose, gynecomastia

Uncommon (0.1% to 1%): Elevated blood lactate dehydrogenase, elevated blood testosterone

Rare (less than 0.1%): Benign pituitary tumor

Postmarketing reports: Pituitary apoplexy

Cardiovascular

Very common (10% or more): Hot flashes (up to 65.5%)

Common (1% to 10%): Blushing

Uncommon (0.1% to 1%): Hematoma, peripheral edema

Rare (less than 0.1%): Palpitations, ventricular extrasystoles

Local

Very common (10% or more): Implant/application site reaction (up to 51.1%)

Common (1% to 10%): Implant/application site injury, keloid scar, scar, suture-related complication, post procedural pain

Postmarketing reports: Implant breakage

Implant/application site reactions includes discomfort, bruising, soreness, pain, tenderness, tingling, itching, erythema, inflammation, protrusion, and swelling.

Other

Common (1% to 10%): Asthenia, fatigue

Uncommon (0.1% to 1%): Sexual dysfunction, breast pain, breast tenderness, pain (exacerbated and non specific), swelling, feeling cold, bruising, malaise

Rare (less than 0.1%): Wound infection, disease progression

Psychiatric

Common (1% to 10%): Mood changes, depression, decreased libido, insomnia

Uncommon (0.1% to 1%): Irritability

Musculoskeletal

Common (1% to 10%): Arthralgia, pain in the extremities

Uncommon (0.1% to 1%): Back pain, muscle spasm, muscle infiltration, neck pain, bone pain, muscle twitching, myalgia

Dermatologic

Common (1% to 10%): Contusion, hypotrichosis, hypertrichosis

Uncommon (0.1% to 1%): Night sweats, pruritus, hyperhidrosis

Rare (less than 0.1%): Skin infection

Gastrointestinal

Common (1% to 10%): Constipation

Uncommon (0.1% to 1%): Abdominal discomfort, nausea

Genitourinary

Common (1% to 10%): Erectile dysfunction, testicular atrophy, pollakisuria, urinary retention

Uncommon (0.1% to 1%): Male genital pruritus, dysuria, hematuria, elevated prostatic acid phosphatase, ureteral stent occlusion, urinary frequency

Rare (less than 0.1%): Dysmenorrhea, menorrhagia, metrorrhagia

General

Supprelin LA(R):

-The most common adverse reactions involved the implant site, including bruising, pain, soreness, erythema, and swelling.

Hematologic

Uncommon (0.1% to 1%): Anemia

Hepatic

Common (1% to 10%): Hepatic disorder

Uncommon (0.1% to 1%): Elevated aspartate aminotransferase

Postmarketing reports: Drug-induced liver injury

Immunologic

Rare (less than 0.1%): Influenza-like illness

Metabolic

Common (1% to 10%): Fluid retention, hypercalcemia, hypercholesterolemia, food cravings, increased appetite, weight gain, weight loss

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Tremor, lethargy

Rare (less than 0.1%): Migraine

Postmarketing reports: Seizures/convulsions

Renal

Common (1% to 10%): Impaired renal function

Uncommon (0.1% to 1%): Renal failure, nephrolithiasis, decreased creatinine clearance

Respiratory

Common (1% to 10%): Exertional dyspnea

Rare (less than 0.1%): Epistaxis

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Vantas (www.drugs.com/vantas.html).